Best treatments for chronic-phase myeloid leukemia
3 products may treat chronic-phase myeloid leukemia, spanning FDA drug classes such as kinase inhibitor. The current highest-rated option is danziten. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 3 drugs we list for chronic-phase myeloid leukemia, none are yet flagged as generics in our price data, spanning classes such as kinase inhibitor. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for chronic-phase myeloid leukemia — so confirm the right choice with your prescriber.
Top-rated picks for chronic-phase myeloid leukemia: 1. Danziten · 2. Tasigna · 3. Cavhanza
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 70/100 | Prescription | Tablet | Kinase Inhibitor | No data | — | View → | |
| 2 | 70/100 | Prescription | Capsule | Kinase Inhibitor | No data | — | View → | |
| 3 | Not yet rated | Prescription | Tablet | Kinase Inhibitor | No data | — | View → |
Narrow by drug class
Explore the class hubs: kinase inhibitor
Full ranking · 3 treatments
danziten
Boxed warningPrescriptionFDA-sourced
Danziten (Nilotinib Tartrate) is a kinase inhibitor used to treat Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors.
Price varies
tasigna
Boxed warningPrescriptionFDA-sourced
Tasigna (Nilotinib Hydrochloride) is a kinase inhibitor used to treat Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia.
Price varies
cavhanza
PrescriptionFDA-sourced
Cavhanza (Nilotinib) is a kinase inhibitor used to treat Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia, Gastrointestinal Stromal Tumors.
Price varies
Frequently asked
- What treats chronic-phase myeloid leukemia?
- Our catalog lists 3 products that may treat chronic-phase myeloid leukemia, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is danziten.
- What is the best-rated treatment for chronic-phase myeloid leukemia?
- By our independent recall-safety rating — not an efficacy measure — danziten ranks highest among the products we list for chronic-phase myeloid leukemia. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat chronic-phase myeloid leukemia?
- Treatments for chronic-phase myeloid leukemia span FDA drug classes including kinase inhibitor. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.